1,126
Views
1
CrossRef citations to date
0
Altmetric
Articles

Are TRUS-guided prostate biopsies in clinical practice robust enough to make a correct assessment of the surgical strategy in prostatectomies? Poor correlation between preoperative prostate biopsies and postoperative specimens

&
Pages 282-286 | Received 25 Mar 2019, Accepted 05 Aug 2019, Published online: 27 Aug 2019

References

  • https://www.cancercentrum.se/samverkan/cancerdiagnoser/prostata/vardprogram/gallande-vardprogram-prostatacancer/.
  • Areal Calama J. [Conventional transrectal ultrasound guided biopsy. Current role, indications, techniques and limitations]. Arch Esp Urol. 2015;68:282–295.
  • Serefoglu EC, Altinova S, Ugras NS, et al. How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can Urol Assoc J. 2013;7:E293–E298.
  • Tei H, Miyake H, Harada K, et al. Detection of significant prostate cancer according to anatomical areas of sampling cores obtained with transrectal systematic 12-core biopsy. Curr Urol. 2014;8:91–95.
  • Iremashvili V, Pelaez L, Jorda M, et al. Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens. Urology. 2012;79:37–42.
  • Chambó RC, Tsuji FH, de Oliveira Lima F, et al. What is the ideal core number for ultrasound-guided prostate biopsy? Korean J Urol. 2014;55:725–731.
  • Miyoshi Y, Furuya M, Teranishi J, et al. Comparison of 12- and 16-core prostate biopsy in japanese patients with serum prostate-specific antigen level of 4.0–20.0 ng/mL. Urol J. 2014;11:1609–1614.
  • Bladou F, Fogaing C, Levental M, et al. Transrectal ultrasound-guided biopsy for prostate cancer detection: systematic and/or magnetic-resonance imaging-targeted. CUAJ. 2017;11:E330–E337.
  • Siddiqui MM, Rais-Bahrami S, Truong H, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013;64:713–719.
  • Weiss B, Loeb S. MRI/Ultrasound fusion biopsy versus standard 12-core biopsy. Rev Urol. 2015;17:113–115.
  • Sinnott M, Falzarano SM, Hernandez AV, et al. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy. Prostate. 2012;72:1179–1186.
  • Suer E, Gokce MI, Gulpinar O, et al. How significant is upgrade in Gleason score between prostate biopsy and radical prostatectomy pathology while discussing less invasive treatment options? Scand J Urol. 2014;48:177–182.
  • Chung MS, Lee SH, Lee DH, et al. Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy? Yonsei Med J. 2013;54:902–906.
  • Obek C, Louis P, Civantos F, et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol. 1999;161:494–498.
  • Pietzak EJ, Resnick MJ, Mucksavage P, et al. Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates. Urology. 2014;84:380–385.
  • Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol. 2015;68:438–450.
  • Demirel HC, Davis JW. Multiparametric magnetic resonance imaging: overview of the technique, clinical applications in prostate biopsy and future directions. Turk J Urol. 2018;44:93–102.
  • Keulers BJ, Scheltinga MR, Houterman S, et al. Surgeons underestimate their patients' desire for preoperative information. World J Surg. 2008;32:964–970.
  • Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008 ;358:1250–1261.